Efficacy of Longdan Xiegan Decoction on the Treatment of Eczema: A Systematic Review and Meta-Analysis
- PMID: 33680065
- PMCID: PMC7906809
- DOI: 10.1155/2021/8836117
Efficacy of Longdan Xiegan Decoction on the Treatment of Eczema: A Systematic Review and Meta-Analysis
Abstract
Background: Longdan Xiegan decoction (LDXGD) has been widely used in the treatment of eczema. In recent years, randomized controlled trials (RCTs) of LDXGD for the treatment of eczema have gradually increased. Most of the results show that LDXGD is effective in treating eczema. However, whether these conclusions are reliable or not requires meta-analysis.
Objective: This study aimed to systematically evaluate the clinical efficacy of LDXGD in the treatment of eczema.
Materials and methods: Seven electronic databases, including PubMed, Excerpta Medica Database (EMBASE), Cochrane Library, Chinese Biomedical Literature on Disc (CBM), China National Knowledge Infrastructure (CNKI), WanFang, and Chinese Science and Technology Periodical Database (VIP) were systematically searched from their inception until January 2021. Risk of bias was assessed using criteria from the Cochrane Collaboration and meta-analysis was conducted on the screened literature data using Review Manage (RevMan 5.3). Then, to assess the quality of evidence, the GRADE criteria was adopted.
Results: 14 RCTs with 1080 participants were identified. Meta-analysis indicated that compared with western medicine (WM), the cure rate and the total effective rate of LDXGD in treating eczema were higher. Meanwhile, the recurrence rate and the levels of interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor (TNF-α) after treatment were lower. The adverse reaction was reported in 5 out of 14 studies without significant statistical difference. According to GRADE criteria, the quality of evidence was low for all outcomes except for the cure rate (moderate-quality evidence) and the total effective rate (moderate-quality evidence).
Conclusion: The clinical efficacy of LDXGD in the treatment of eczema was more effective compared with the one of conventional WM alone. However, due to the limitation of the quality of the included studies, additional studies are required to further confirm these results.
Copyright © 2021 Ziteng Hu et al.
Conflict of interest statement
The author declares that there are no conflicts of interest in this article.
Figures
References
-
- Sun H. Y. Analysis of the etiology and treatment of eczema in Chinese and WM. Nei Mongol Journal of Traditional Chinese Medicine. 2015;34(1):132–134.
-
- Diao Q. C., Yang Z. B., Duan Y. Q. Consensus of experts in TCM diagnosis and treatment of eczema (2016) Chinese Journal of Dermatovenereology of Integrated Traditional and WM. 2018;17(2):181–183.
-
- Sun Z. G., Lu J. Z., Zhou S. J. Advances in the treatment of eczema with Traditional Chinese medicine. China Journal of Traditional Chinese Medicine and Pharmacy. 2017;32(8):3617–3619.
-
- Li C. C., Li S. T., Yin Y. H. Overview of the occurrence of eczema and acupuncture treatment. Liaoning Journal of Traditional Chinese Medicine. 2018;45(12):2676–2680.
-
- Li G. R., Yang S. F., Ou H. Y. Difficulties in the treatment of eczema and countermeasures of Traditional Chinese medicine. Chinese Journal of Dermatovenereology of Integrated Traditional and WM. 2010;9(4):253–255.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
